Surgical mesh implants market to hit $5.46 billion by 2030

The Business Research Company says the surgical mesh implants market will grow from $3.97 billion in 2025 to $4.24 billion in 2026, then reach $5.46 billion by 2030. Demand is being driven by more hernia and pelvic repair cases, wider use of minimally invasive surgery and new mesh materials.

Why it matters: - Surgical mesh implants are used to reinforce weakened tissue in procedures such as hernia repair and pelvic surgery. - Growth in the market points to rising surgical volumes, more minimally invasive procedures and higher demand for devices that support faster recovery. - The forecast suggests medical device suppliers, hospitals and surgeons will keep investing in mesh technologies and related surgical capabilities.

What happened: - The Business Research Company released a new report on the global surgical mesh implants market. - The market is projected to rise from $3.97 billion in 2025 to $4.24 billion in 2026. - The report forecasts the market will reach $5.46 billion by 2030. - The report gives a 2026-2035 outlook and includes regional and segment analysis. - A free sample of the report is available here. - The full report is available here.

The details: - The market is expected to grow at a compound annual growth rate of 6.8% in 2026. - The forecast period points to a 6.5% CAGR through 2030. - Hernia cases and pelvic organ prolapse cases are lifting demand. - Better mesh materials are supporting adoption. - More investment in hospital infrastructure is adding to growth. - Higher volumes of laparoscopic and open surgeries are expanding the addressable market. - Cost-effective surgical options are also supporting demand. - Surgical mesh implants can be made from synthetic or biological materials. - These devices support damaged or weakened tissue and can help natural tissue growth and healing. - The implants are used mainly in soft tissue reinforcement surgeries. - Robotic-assisted surgery adoption, especially for minimally invasive procedures, is expected to support future growth. - Bioabsorbable and hybrid mesh products are emerging as key product trends. - Demand is rising for personalized surgical mesh solutions, better biocompatible materials and faster post-surgical recovery. - Pelvic health care demand is increasing.

Between the lines: - The report frames minimally invasive surgery as a major demand driver because smaller-incision procedures usually mean shorter hospital stays, less pain and faster recovery. - Intuitive Surgical reported nearly 2.7 million procedures using its products in 2024, up 17% from a year earlier. - Intuitive Surgical said total procedures performed using its da Vinci platforms have reached close to 17 million. - North America was the largest regional market in 2025. - Asia-Pacific is expected to be the fastest-growing region over the next several years. - The report also covers South East Asia, Western and Eastern Europe, South America, the Middle East and Africa. - The 2026 edition adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics and updated graphics.

What's next: - Wider use of robotic-assisted surgery and minimally invasive techniques is likely to keep lifting mesh demand. - Innovation in bioabsorbable, hybrid and biocompatible mesh products should shape the next phase of competition. - Asia-Pacific’s growth rate could narrow the gap with North America as surgical demand expands. - The Business Research Company is promoting expert contact options for buyers seeking the report or additional market guidance.

The bottom line: - Surgical mesh implants are moving from a steady-growth niche into a larger global market supported by procedure growth, material innovation and the shift toward less invasive surgery.